Search research articles
Contact Us
Filters
Showing results (51-60 of 177) with videos related to
Page
of 18
Sort By:
European Heart Journal
|
August 1, 1982
Paradoxical embolism. A review of cases diagnosed during life
R C Leonard, E Neville, R J Hall
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1993
Should we regard CA125 as the indication to treat relapsing ovarian cancer?
J Fisken, R C Leonard, J E Roulston
Disease Markers
|
January 1, 1989
Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoring
J Fisken, R C Leonard, J E Roulston
British Journal of Cancer
|
June 1, 1991
A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party
R L Hayward, R C Leonard, R J Prescott
Cancer Research
|
October 15, 1990
Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer
R C Leonard, L W Duncan, F G Hay
Disease Markers
|
June 1, 1993
An assessment of the clinical usefulness of two serum markers, CA15 3 and HMFG 2 in localized and metastatic breast cancer
P Bliss, J Fisken, J Roulsten, et al.
The British Journal of Cancer. Supplement
|
June 1, 1991
Establishment and characterisation of two new small cell lung cancer cell lines--one from a patient with previous familial retinoblastoma
F G Hay, L W Duncan, R C Leonard
Cancer Drug Delivery
|
January 1, 1984
High-dose alkylating agent therapy: a review of clinical experiences
M A Cornbleet, R C Leonard, J F Smyth
Cancer Treatment Reviews
|
October 1, 1994
Infusional 5-fluorouracil in breast cancer
J S Ng, D A Cameron, R C Leonard
British Medical Journal (Clinical Research Ed.)
|
April 9, 1983
Hypothermia during chemotherapy for Hodgkin's disease
M J Jackson, S J Proctor, R C Leonard
Page
of 18
Search research articles
Search
Showing results (51-60 of 177) with videos related to
Sort By:
Page
of 18
European Heart Journal
|
August 1, 1982
Paradoxical embolism. A review of cases diagnosed during life
R C Leonard, E Neville, R J Hall
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1993
Should we regard CA125 as the indication to treat relapsing ovarian cancer?
J Fisken, R C Leonard, J E Roulston
Disease Markers
|
January 1, 1989
Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoring
J Fisken, R C Leonard, J E Roulston
British Journal of Cancer
|
June 1, 1991
A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party
R L Hayward, R C Leonard, R J Prescott
Cancer Research
|
October 15, 1990
Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer
R C Leonard, L W Duncan, F G Hay
Disease Markers
|
June 1, 1993
An assessment of the clinical usefulness of two serum markers, CA15 3 and HMFG 2 in localized and metastatic breast cancer
P Bliss, J Fisken, J Roulsten, et al.
The British Journal of Cancer. Supplement
|
June 1, 1991
Establishment and characterisation of two new small cell lung cancer cell lines--one from a patient with previous familial retinoblastoma
F G Hay, L W Duncan, R C Leonard
Cancer Drug Delivery
|
January 1, 1984
High-dose alkylating agent therapy: a review of clinical experiences
M A Cornbleet, R C Leonard, J F Smyth
Cancer Treatment Reviews
|
October 1, 1994
Infusional 5-fluorouracil in breast cancer
J S Ng, D A Cameron, R C Leonard
British Medical Journal (Clinical Research Ed.)
|
April 9, 1983
Hypothermia during chemotherapy for Hodgkin's disease
M J Jackson, S J Proctor, R C Leonard
Page
of 18